Status:
UNKNOWN
Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus
Lead Sponsor:
University Hospital, Antwerp
Conditions:
NAFLD
Type 1 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by intrahepatic fat accumulation. It is closely related to insulin resistance. To date, it remains unclear whether NAFLD is common...
Detailed Description
This study aims to characterize and follow a thoroughly characterized cohort of adult type 1 diabetes patients free from secondary liver disease due to excessive alcohol usage, viral hepatitis, alfa-1...
Eligibility Criteria
Inclusion
- Type 1 diabetes
- Adult age
- Informed consent given
Exclusion
- Secondary liver disease
- Excess alcohol usage
- Pregnancy
- Use of steatogenic medication
- Active cancer or oncological treatment
- History of organ transplantation
Key Trial Info
Start Date :
September 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2025
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04664036
Start Date
September 17 2018
End Date
July 30 2025
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp University Hospital
Edegem, Antwerp, Belgium, 2650